Last update:

Oncology news

FDA grants expanded access to the pancreatic cancer drug daraxonrasib

The U.S. Food and Drug Administration (FDA) has granted expanded access for the use of an experimental pancreatic cancer drug, daraxonrasib. This means the drug will be available for early access to those who previously received ...

Complete remission of aggressive pituitary tumor achieved through immunotherapy

Researchers at the University of Cincinnati Gardner Neuroscience Institute's Brain Tumor Center have been confirmed as the first in the world to achieve complete remission of a rare pituitary cancer using a novel immunotherapy ...

Dietary fats shape pancreatic cancer risk via ferroptosis

For decades, the relationship between fat and cancer has been treated as a question of quantity: Eat less fat, reduce your risk of developing cancer. But new research published April 29 in Cancer Discovery shows that for ...